Uncategorized
VIDEO: Oyster Point developing nasal spray for dry eye treatment
CHICAGO ― At the Ophthalmology Innovation Summit at AAO, Jeffrey Nau, PhD, president and CEO of Oyster Point Pharma, discusses the company’s progress toward the development of a nasal spray targeting the trigeminal nerve to increase tear production in treating dry eye.